カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

世界のプロゲスチン製剤市場2022年：プロゲスチン経口、プロゲスチン注射、プロゲスチンサスペンド/ジェル

◆英語タイトル：Global Progestin Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
	◆商品コード：GIR22MY8947 ◆発行会社（リサーチ会社）：GlobalInfoResearch ◆発行日：2022年5月（※2025年版があります。お問い合わせください。） ◆ページ数：92 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（注文後2-3日） ◆調査対象地域：グローバル ◆産業分野：医薬品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥528,960	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,220 ⇒換算￥793,440	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,057,920	見積依頼/購入/質問フォーム

★GlobalInfoResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

プロゲスチン製剤市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のプロゲスチン製剤の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

プロゲスチン製剤市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・プロゲスチン経口、プロゲスチン注射、プロゲスチンサスペンド/ジェル

用途別セグメントは次のように区分されます。
・病院、クリニック、薬局、ドラッグストア

世界のプロゲスチン製剤市場の主要な市場プレーヤーは以下のとおりです。
・Merck、Teva Generics、Zhejiang Xianju Pharmaceutical、Zhejiang Aisheng Pharmaceutical、Besins Healthcare、Zhejiang Medicine、Virtus Pharmaceuticals, LLC、BionPharma

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、プロゲスチン製剤製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なプロゲスチン製剤メーカーの企業概要、2019年～2022年までのプロゲスチン製剤の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なプロゲスチン製剤メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別プロゲスチン製剤の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのプロゲスチン製剤の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのプロゲスチン製剤市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびプロゲスチン製剤の産業チェーンを掲載しています。
・第13、14、15章では、プロゲスチン製剤の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Merck、Teva Generics、Zhejiang Xianju Pharmaceutical、Zhejiang Aisheng Pharmaceutical、Besins Healthcare、Zhejiang Medicine、Virtus Pharmaceuticals, LLC、BionPharma
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：プロゲスチン経口、プロゲスチン注射、プロゲスチンサスペンド/ジェル
・用途別分析2017年-2028年：病院、クリニック、薬局、ドラッグストア
・プロゲスチン製剤の北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ
・プロゲスチン製剤のヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア
・プロゲスチン製剤のアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア
・プロゲスチン製剤の南米市場規模2017年-2028年：ブラジル、アルゼンチン
・プロゲスチン製剤の中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Progestin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Progestin market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Progestin global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Progestin Oral segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Progestin include Merck, Teva Generics, Zhejiang Xianju Pharmaceutical, Zhejiang Aisheng Pharmaceutical, and Besins Healthcare, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Progestin market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Progestin Oral
Progestin Injection
Progestin Suspended/Gel
Market segment by Application can be divided into
Hospital
Clinic
Pharmacies & Drug Stores
The key market players for global Progestin market are listed below:
Merck
Teva Generics
Zhejiang Xianju Pharmaceutical
Zhejiang Aisheng Pharmaceutical
Besins Healthcare
Zhejiang Medicine
Virtus Pharmaceuticals, LLC
BionPharma
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Progestin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Progestin, with price, sales, revenue and global market share of Progestin from 2019 to 2022.
Chapter 3, the Progestin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Progestin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Progestin market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Progestin.
Chapter 13, 14, and 15, to describe Progestin sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Progestin Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Progestin Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Progestin Oral
1.2.3 Progestin Injection
1.2.4 Progestin Suspended/Gel
1.3 Market Analysis by Application
1.3.1 Overview: Global Progestin Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Pharmacies & Drug Stores
1.4 Global Progestin Market Size & Forecast
1.4.1 Global Progestin Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Progestin Sales in Volume (2017-2028)
1.4.3 Global Progestin Price (2017-2028)
1.5 Global Progestin Production Capacity Analysis
1.5.1 Global Progestin Total Production Capacity (2017-2028)
1.5.2 Global Progestin Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Progestin Market Drivers
1.6.2 Progestin Market Restraints
1.6.3 Progestin Trends Analysis
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Progestin Product and Services
2.1.4 Merck Progestin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Teva Generics
2.2.1 Teva Generics Details
2.2.2 Teva Generics Major Business
2.2.3 Teva Generics Progestin Product and Services
2.2.4 Teva Generics Progestin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Zhejiang Xianju Pharmaceutical
2.3.1 Zhejiang Xianju Pharmaceutical Details
2.3.2 Zhejiang Xianju Pharmaceutical Major Business
2.3.3 Zhejiang Xianju Pharmaceutical Progestin Product and Services
2.3.4 Zhejiang Xianju Pharmaceutical Progestin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Zhejiang Aisheng Pharmaceutical
2.4.1 Zhejiang Aisheng Pharmaceutical Details
2.4.2 Zhejiang Aisheng Pharmaceutical Major Business
2.4.3 Zhejiang Aisheng Pharmaceutical Progestin Product and Services
2.4.4 Zhejiang Aisheng Pharmaceutical Progestin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Besins Healthcare
2.5.1 Besins Healthcare Details
2.5.2 Besins Healthcare Major Business
2.5.3 Besins Healthcare Progestin Product and Services
2.5.4 Besins Healthcare Progestin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Zhejiang Medicine
2.6.1 Zhejiang Medicine Details
2.6.2 Zhejiang Medicine Major Business
2.6.3 Zhejiang Medicine Progestin Product and Services
2.6.4 Zhejiang Medicine Progestin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Virtus Pharmaceuticals, LLC
2.7.1 Virtus Pharmaceuticals, LLC Details
2.7.2 Virtus Pharmaceuticals, LLC Major Business
2.7.3 Virtus Pharmaceuticals, LLC Progestin Product and Services
2.7.4 Virtus Pharmaceuticals, LLC Progestin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 BionPharma
2.8.1 BionPharma Details
2.8.2 BionPharma Major Business
2.8.3 BionPharma Progestin Product and Services
2.8.4 BionPharma Progestin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Progestin Breakdown Data by Manufacturer
3.1 Global Progestin Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Progestin Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Progestin
3.4 Market Concentration Rate
3.4.1 Top 3 Progestin Manufacturer Market Share in 2021
3.4.2 Top 6 Progestin Manufacturer Market Share in 2021
3.5 Global Progestin Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Progestin Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Progestin Market Size by Region
4.1.1 Global Progestin Sales in Volume by Region (2017-2028)
4.1.2 Global Progestin Revenue by Region (2017-2028)
4.2 North America Progestin Revenue (2017-2028)
4.3 Europe Progestin Revenue (2017-2028)
4.4 Asia-Pacific Progestin Revenue (2017-2028)
4.5 South America Progestin Revenue (2017-2028)
4.6 Middle East and Africa Progestin Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Progestin Sales in Volume by Type (2017-2028)
5.2 Global Progestin Revenue by Type (2017-2028)
5.3 Global Progestin Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Progestin Sales in Volume by Application (2017-2028)
6.2 Global Progestin Revenue by Application (2017-2028)
6.3 Global Progestin Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Progestin Sales by Type (2017-2028)
7.2 North America Progestin Sales by Application (2017-2028)
7.3 North America Progestin Market Size by Country
7.3.1 North America Progestin Sales in Volume by Country (2017-2028)
7.3.2 North America Progestin Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Progestin Sales by Type (2017-2028)
8.2 Europe Progestin Sales by Application (2017-2028)
8.3 Europe Progestin Market Size by Country
8.3.1 Europe Progestin Sales in Volume by Country (2017-2028)
8.3.2 Europe Progestin Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Progestin Sales by Type (2017-2028)
9.2 Asia-Pacific Progestin Sales by Application (2017-2028)
9.3 Asia-Pacific Progestin Market Size by Region
9.3.1 Asia-Pacific Progestin Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Progestin Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Progestin Sales by Type (2017-2028)
10.2 South America Progestin Sales by Application (2017-2028)
10.3 South America Progestin Market Size by Country
10.3.1 South America Progestin Sales in Volume by Country (2017-2028)
10.3.2 South America Progestin Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Progestin Sales by Type (2017-2028)
11.2 Middle East & Africa Progestin Sales by Application (2017-2028)
11.3 Middle East & Africa Progestin Market Size by Country
11.3.1 Middle East & Africa Progestin Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Progestin Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Progestin and Key Manufacturers
12.2 Manufacturing Costs Percentage of Progestin
12.3 Progestin Production Process
12.4 Progestin Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Progestin Typical Distributors
13.3 Progestin Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Progestin Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Progestin Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck Progestin Product and Services
Table 6. Merck Progestin Sales (Ton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Teva Generics Basic Information, Manufacturing Base and Competitors
Table 8. Teva Generics Major Business
Table 9. Teva Generics Progestin Product and Services
Table 10. Teva Generics Progestin Sales (Ton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Zhejiang Xianju Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 12. Zhejiang Xianju Pharmaceutical Major Business
Table 13. Zhejiang Xianju Pharmaceutical Progestin Product and Services
Table 14. Zhejiang Xianju Pharmaceutical Progestin Sales (Ton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Zhejiang Aisheng Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 16. Zhejiang Aisheng Pharmaceutical Major Business
Table 17. Zhejiang Aisheng Pharmaceutical Progestin Product and Services
Table 18. Zhejiang Aisheng Pharmaceutical Progestin Sales (Ton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Besins Healthcare Basic Information, Manufacturing Base and Competitors
Table 20. Besins Healthcare Major Business
Table 21. Besins Healthcare Progestin Product and Services
Table 22. Besins Healthcare Progestin Sales (Ton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Zhejiang Medicine Basic Information, Manufacturing Base and Competitors
Table 24. Zhejiang Medicine Major Business
Table 25. Zhejiang Medicine Progestin Product and Services
Table 26. Zhejiang Medicine Progestin Sales (Ton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Virtus Pharmaceuticals, LLC Basic Information, Manufacturing Base and Competitors
Table 28. Virtus Pharmaceuticals, LLC Major Business
Table 29. Virtus Pharmaceuticals, LLC Progestin Product and Services
Table 30. Virtus Pharmaceuticals, LLC Progestin Sales (Ton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. BionPharma Basic Information, Manufacturing Base and Competitors
Table 32. BionPharma Major Business
Table 33. BionPharma Progestin Product and Services
Table 34. BionPharma Progestin Sales (Ton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Global Progestin Sales by Manufacturer (2019, 2020, 2021, and 2022) & (Ton)
Table 36. Global Progestin Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 37. Market Position of Manufacturers in Progestin, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 38. Global Progestin Production Capacity by Company, (Ton): 2020 VS 2021
Table 39. Head Office and Progestin Production Site of Key Manufacturer
Table 40. Progestin New Entrant and Capacity Expansion Plans
Table 41. Progestin Mergers & Acquisitions in the Past Five Years
Table 42. Global Progestin Sales by Region (2017-2022) & (Ton)
Table 43. Global Progestin Sales by Region (2023-2028) & (Ton)
Table 44. Global Progestin Revenue by Region (2017-2022) & (USD Million)
Table 45. Global Progestin Revenue by Region (2023-2028) & (USD Million)
Table 46. Global Progestin Sales by Type (2017-2022) & (Ton)
Table 47. Global Progestin Sales by Type (2023-2028) & (Ton)
Table 48. Global Progestin Revenue by Type (2017-2022) & (USD Million)
Table 49. Global Progestin Revenue by Type (2023-2028) & (USD Million)
Table 50. Global Progestin Price by Type (2017-2022) & (US$/Ton)
Table 51. Global Progestin Price by Type (2023-2028) & (US$/Ton)
Table 52. Global Progestin Sales by Application (2017-2022) & (Ton)
Table 53. Global Progestin Sales by Application (2023-2028) & (Ton)
Table 54. Global Progestin Revenue by Application (2017-2022) & (USD Million)
Table 55. Global Progestin Revenue by Application (2023-2028) & (USD Million)
Table 56. Global Progestin Price by Application (2017-2022) & (US$/Ton)
Table 57. Global Progestin Price by Application (2023-2028) & (US$/Ton)
Table 58. North America Progestin Sales by Country (2017-2022) & (Ton)
Table 59. North America Progestin Sales by Country (2023-2028) & (Ton)
Table 60. North America Progestin Revenue by Country (2017-2022) & (USD Million)
Table 61. North America Progestin Revenue by Country (2023-2028) & (USD Million)
Table 62. North America Progestin Sales by Type (2017-2022) & (Ton)
Table 63. North America Progestin Sales by Type (2023-2028) & (Ton)
Table 64. North America Progestin Sales by Application (2017-2022) & (Ton)
Table 65. North America Progestin Sales by Application (2023-2028) & (Ton)
Table 66. Europe Progestin Sales by Country (2017-2022) & (Ton)
Table 67. Europe Progestin Sales by Country (2023-2028) & (Ton)
Table 68. Europe Progestin Revenue by Country (2017-2022) & (USD Million)
Table 69. Europe Progestin Revenue by Country (2023-2028) & (USD Million)
Table 70. Europe Progestin Sales by Type (2017-2022) & (Ton)
Table 71. Europe Progestin Sales by Type (2023-2028) & (Ton)
Table 72. Europe Progestin Sales by Application (2017-2022) & (Ton)
Table 73. Europe Progestin Sales by Application (2023-2028) & (Ton)
Table 74. Asia-Pacific Progestin Sales by Region (2017-2022) & (Ton)
Table 75. Asia-Pacific Progestin Sales by Region (2023-2028) & (Ton)
Table 76. Asia-Pacific Progestin Revenue by Region (2017-2022) & (USD Million)
Table 77. Asia-Pacific Progestin Revenue by Region (2023-2028) & (USD Million)
Table 78. Asia-Pacific Progestin Sales by Type (2017-2022) & (Ton)
Table 79. Asia-Pacific Progestin Sales by Type (2023-2028) & (Ton)
Table 80. Asia-Pacific Progestin Sales by Application (2017-2022) & (Ton)
Table 81. Asia-Pacific Progestin Sales by Application (2023-2028) & (Ton)
Table 82. South America Progestin Sales by Country (2017-2022) & (Ton)
Table 83. South America Progestin Sales by Country (2023-2028) & (Ton)
Table 84. South America Progestin Revenue by Country (2017-2022) & (USD Million)
Table 85. South America Progestin Revenue by Country (2023-2028) & (USD Million)
Table 86. South America Progestin Sales by Type (2017-2022) & (Ton)
Table 87. South America Progestin Sales by Type (2023-2028) & (Ton)
Table 88. South America Progestin Sales by Application (2017-2022) & (Ton)
Table 89. South America Progestin Sales by Application (2023-2028) & (Ton)
Table 90. Middle East & Africa Progestin Sales by Region (2017-2022) & (Ton)
Table 91. Middle East & Africa Progestin Sales by Region (2023-2028) & (Ton)
Table 92. Middle East & Africa Progestin Revenue by Region (2017-2022) & (USD Million)
Table 93. Middle East & Africa Progestin Revenue by Region (2023-2028) & (USD Million)
Table 94. Middle East & Africa Progestin Sales by Type (2017-2022) & (Ton)
Table 95. Middle East & Africa Progestin Sales by Type (2023-2028) & (Ton)
Table 96. Middle East & Africa Progestin Sales by Application (2017-2022) & (Ton)
Table 97. Middle East & Africa Progestin Sales by Application (2023-2028) & (Ton)
Table 98. Progestin Raw Material
Table 99. Key Manufacturers of Progestin Raw Materials
Table 100. Direct Channel Pros & Cons
Table 101. Indirect Channel Pros & Cons
Table 102. Progestin Typical Distributors
Table 103. Progestin Typical Customers
List of Figures
Figure 1. Progestin Picture
Figure 2. Global Progestin Revenue Market Share by Type in 2021
Figure 3. Progestin Oral
Figure 4. Progestin Injection
Figure 5. Progestin Suspended/Gel
Figure 6. Global Progestin Revenue Market Share by Application in 2021
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Pharmacies & Drug Stores
Figure 10. Global Progestin Revenue, (USD Million) & (Ton): 2017 & 2021 & 2028
Figure 11. Global Progestin Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Progestin Sales (2017-2028) & (Ton)
Figure 13. Global Progestin Price (2017-2028) & (US$/Ton)
Figure 14. Global Progestin Production Capacity (2017-2028) & (Ton)
Figure 15. Global Progestin Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Progestin Market Drivers
Figure 17. Progestin Market Restraints
Figure 18. Progestin Market Trends
Figure 19. Global Progestin Sales Market Share by Manufacturer in 2021
Figure 20. Global Progestin Revenue Market Share by Manufacturer in 2021
Figure 21. Progestin Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Progestin Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Progestin Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Progestin Sales Market Share by Region (2017-2028)
Figure 25. Global Progestin Revenue Market Share by Region (2017-2028)
Figure 26. North America Progestin Revenue (2017-2028) & (USD Million)
Figure 27. Europe Progestin Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Progestin Revenue (2017-2028) & (USD Million)
Figure 29. South America Progestin Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Progestin Revenue (2017-2028) & (USD Million)
Figure 31. Global Progestin Sales Market Share by Type (2017-2028)
Figure 32. Global Progestin Revenue Market Share by Type (2017-2028)
Figure 33. Global Progestin Price by Type (2017-2028) & (US$/Ton)
Figure 34. Global Progestin Sales Market Share by Application (2017-2028)
Figure 35. Global Progestin Revenue Market Share by Application (2017-2028)
Figure 36. Global Progestin Price by Application (2017-2028) & (US$/Ton)
Figure 37. North America Progestin Sales Market Share by Type (2017-2028)
Figure 38. North America Progestin Sales Market Share by Application (2017-2028)
Figure 39. North America Progestin Sales Market Share by Country (2017-2028)
Figure 40. North America Progestin Revenue Market Share by Country (2017-2028)
Figure 41. United States Progestin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Progestin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Progestin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Progestin Sales Market Share by Type (2017-2028)
Figure 45. Europe Progestin Sales Market Share by Application (2017-2028)
Figure 46. Europe Progestin Sales Market Share by Country (2017-2028)
Figure 47. Europe Progestin Revenue Market Share by Country (2017-2028)
Figure 48. Germany Progestin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Progestin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Progestin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Progestin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Progestin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Progestin Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Progestin Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Progestin Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Progestin Revenue Market Share by Region (2017-2028)
Figure 57. China Progestin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Progestin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Progestin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Progestin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Progestin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Progestin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Progestin Sales Market Share by Type (2017-2028)
Figure 64. South America Progestin Sales Market Share by Application (2017-2028)
Figure 65. South America Progestin Sales Market Share by Country (2017-2028)
Figure 66. South America Progestin Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Progestin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Progestin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Progestin Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Progestin Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Progestin Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Progestin Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Progestin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Progestin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Progestin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Progestin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Progestin in 2021
Figure 78. Manufacturing Process Analysis of Progestin
Figure 79. Progestin Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のプロゲスチン製剤市場2022年：プロゲスチン経口、プロゲスチン注射、プロゲスチンサスペンド/ジェル(Global Progestin Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界のプロゲスチン製剤市場2022年：プロゲスチン経口、プロゲスチン注射、プロゲスチンサスペンド/ジェル

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp